Visalytics
Visalytics
approved EB-2 (NIW)

Senior Research Specialist

Translational Epidemiology · India · 2025-06-05

Processing Time
20 days
Decision Date
2025-06-05
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance the development of quantitative clinical decision-making tools to enable earlier and more precise interventions for chronic, life-altering diseases. Her work focuses on applying advanced epidemiological and statistical methods to create early detection protocols and personalized treatment strategies. The endeavor aims to improve patient outcomes in high-risk populations while reducing the economic burden of long-term disease management.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses chronic disease treatment and healthcare cost reduction, which are of significant national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 14 publications, 332 citations, and history of funded research demonstrate she is well-positioned to succeed.

3 Waiver Benefit to the US Met

The petitioner's unique expertise in translational epidemiology provides benefits that outweigh the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 14 peer-reviewed journal articles and 332 citations, demonstrating significant influence in the field of nephrology. Evidence included 7 completed peer reviews and funding support from the National Kidney Foundation, satisfying all three Dhanasar prongs. The case highlighted her role in refining therapeutic pathways for complex kidney diseases and drug development.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Grants
Original Contributions
Government Alignment

Similar Cases

Epidemiologist

Healthcare · China

WeGreened EB-2 (NIW) rfe approved
Florida 636 days 2025-09-19
The petitioner proposes to advance precision medicine by discovering disease mechanisms for personalized diagnostics and treatments. Her work involves applying multi-omics analysis, bioinformatics, and machine learning to develop predictive models and biomarker-based strategies for cardiometabolic and chronic kidney diseases.
View Case

Director

Healthcare · South Korea

WeGreened EB-2 (NIW) approved
California 7 days 2024-01-05
The petitioner proposes to conduct epidemiological studies focusing on individuals at risk for kidney and cardiovascular diseases to improve patient health outcomes. Her work involves clarifying the epidemiological terrain and providing actionable insights to advance global health policies and medical treatments.
View Case

Physician

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
Kentucky 2 days 2023-11-30
The petitioner proposes to develop strategies for early drug toxicity recognition, treatment implementation, and the use of novel therapies for chronic, rare, and evolving kidney diseases. This work aims to improve healthcare outcomes for high-risk patient populations and advance global knowledge in the field of nephrology.
View Case

Researcher

Healthcare · China

WeGreened EB-2 (NIW) approved
6 days 2023-08-03
The petitioner proposes to continue her research in clinical medicine, specifically focusing on advancing diagnostic and therapeutic approaches for gastrointestinal cancer. Her work also involves elucidating molecular and signaling pathways contributing to chronic kidney disease (CKD) and developing strategies to enhance hemodialysis (HD) treatments. The endeavor aims to improve clinical outcomes for patients with complex medical conditions and foster pharmaceutical advancements for targeted disease treatment.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 20 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist